Simplex Trading
FOLD

Simplex Trading’s Amicus Therapeutics FOLD Stock Holding History

Simplex Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.7K Sell
6,200
-900
-13% -$12.9K ﹤0.01% 5214
2025
Q4 		$101K Sell
7,100
-28,100
-80% -$276K ﹤0.01% 4989
2025
Q3 		$277K Buy
35,200
+27,900
+382% +$199K ﹤0.01% 4568
2025
Q2 		$41K Buy
7,300
+4,400
+152% +$28.4K ﹤0.01% 6119
2025
Q1 		$23K Sell
2,900
-3,000
-51% -$27.8K ﹤0.01% 6462
2024
Q4 		$55K Buy
5,900
+1,400
+31% +$14.6K ﹤0.01% 5778
2024
Q3 		$48K Sell
4,500
-37,400
-89% -$407K ﹤0.01% 5916
2024
Q2 		$415K Buy
41,900
+6,700
+19% +$68.8K ﹤0.01% 3848
2024
Q1 		$414K Sell
35,200
-16,600
-32% -$212K ﹤0.01% 4039
2023
Q4 		$735K Sell
51,800
-15,500
-23% -$176K ﹤0.01% 3322
2023
Q3 		$818K Buy
67,300
+50,100
+291% +$646K ﹤0.01% 2881
2023
Q2 		$216K Sell
17,200
-13,100
-43% -$155K ﹤0.01% 4215
2023
Q1 		$336K Buy
30,300
+24,600
+432% +$303K ﹤0.01% 3695
2022
Q4 		$69K Sell
5,700
-19,600
-77% -$221K ﹤0.01% 5487
2022
Q3 		$264K Sell
25,300
-138,100
-85% -$1.54M ﹤0.01% 4247
2022
Q2 		$1.75M Buy
163,400
+151,500
+1,273% +$1.25M ﹤0.01% 2006
2022
Q1 		$112K Sell
11,900
-12,600
-51% -$118K ﹤0.01% 5983
2021
Q4 		$282K Sell
24,500
-10,000
-29% -$111K ﹤0.01% 4663
2021
Q3 		$340K Sell
34,500
-900
-3% -$9.21K ﹤0.01% 4700
2021
Q2 		$341K Buy
35,400
+34,737
+5,239% +$339K ﹤0.01% 4757
2021
Q1 		$655K Sell
663
-1,357
-67% -$21K ﹤0.01% 2967
2020
Q4 		$4.66M Buy
2,020
+1,038
+106% +$21.2K 0.01% 1034
2020
Q3 		$1.39M Buy
982
+554
+129% +$8.07K ﹤0.01% 1889
2020
Q2 		$645K Buy
428
+245
+134% +$2.98K ﹤0.01% 2619
2020
Q1 		$169K Sell
183
-147
-45% -$1.4K ﹤0.01% 3786
2019
Q4 		$321K Buy
330
+261
+378% +$2.39K ﹤0.01% 3207
2019
Q3 		$55K Sell
69
-353
-84% -$3.83K ﹤0.01% 4926
2019
Q2 		$526K Sell
422
-251
-37% -$3.19K ﹤0.01% 2514
2019
Q1 		$915K Buy
673
+510
+313% +$6.23K ﹤0.01% 2072
2018
Q4 		$156K Sell
163
-871
-84% -$9.57K ﹤0.01% 3409
2018
Q3 		$1.25M Sell
1,034
-982
-49% -$13.7K ﹤0.01% 1663
2018
Q2 		$3.15M Buy
2,016
+1,630
+422% +$24.6K 0.01% 821
2018
Q1 		$83K Buy
386
+8
+2% +$122 ﹤0.01% 1956
2017
Q4 		$39K Buy
378
+31
+9% +$426 ﹤0.01% 2676
2017
Q3 		$136K Buy
347
+198
+133% +$2.62K 0.01% 1476
2017
Q2 		$42K Sell
149
-141
-49% -$1.14K ﹤0.01% 2550
2017
Q1 		$34K Sell
290
-1,118
-79% -$7.07K ﹤0.01% 2727
2016
Q4 		$68K Buy
1,408
+1,009
+253% +$6.98K ﹤0.01% 1851
2016
Q3 		$103K Sell
399
-36
-8% -$243 0.01% 1509
2016
Q2 		$65K Sell
435
-398
-48% -$2.78K ﹤0.01% 1819
2016
Q1 		$57K Buy
833
+417
+100% +$2.95K ﹤0.01% 1851
2015
Q4 		$18K Buy
416
+251
+152% +$2.26K ﹤0.01% 2784
2015
Q3 		$12K Buy
165
+41
+33% +$643 ﹤0.01% 3266
2015
Q2 		$17K Sell
124
-94
-43% -$1.13K ﹤0.01% 2613
2015
Q1 		$21K Buy
218
+123
+129% +$1.08K ﹤0.01% 2296
2014
Q4 		$25K Buy
+95
New +$652 ﹤0.01% 1880

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Simplex Trading's FOLD Position: Q1 2026 in Review

Simplex Trading sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 18,857 shares — an estimated $270K sold.

Simplex Trading first reported a position in FOLD in Q4 2014 and held it in 32 quarters. The position peaked at $3.58M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Simplex Trading reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 18,857 Amicus Therapeutics shares in Q1 2026, an estimated $270K.
  • Simplex Trading first reported a position in Amicus Therapeutics in Q4 2014 and held it in 32 quarters.
  • Simplex Trading's Amicus Therapeutics position peaked at $3.58M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.